HIV-related renal disease - A clinical and practical approach in the South African context

Southern African Journal of HIV Medicine

Volumn , Issue 10, 2003, Pages 11-14

  Bihl, Geoffrey ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMINOGLYCOSIDE; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; BASIC FIBROBLAST GROWTH FACTOR; CIDOFOVIR; CORTICOSTEROID; COTRIMOXAZOLE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSCARNET; INDINAVIR; ISONIAZID; NEVIRAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTAMIDINE; PROTEINASE INHIBITOR; RIFAMPICIN; SAQUINAVIR; STAVUDINE; SULFADIAZINE; TRANSFORMING GROWTH FACTOR BETA; ZIDOVUDINE;

ACUTE KIDNEY TUBULE NECROSIS; ARTICLE; DEMOGRAPHY; DISEASE COURSE; DRUG ACCUMULATION; EPIDEMIC; FOCAL GLOMERULOSCLEROSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; KIDNEY EPITHELIUM; KIDNEY FAILURE; KIDNEY INTERSTITIUM; KIDNEY STRUCTURE; NEGRO; NEPHRITIS; PATHOGENESIS; PREVALENCE; PROTEINURIA; RACE; RISK FACTOR; SEX RATIO; SOUTH AFRICA;

EID: 0037306630     PISSN: 16089693     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. News. Lancet 2002; 359: 2095.
2. Winston JA, Burns GC, Klotman PE. Treatment of HIV-associated nephropathy. Semin Nephrol 2000; 20: 293-298.
3. Monahan M, Tanji N, Klotman PE. HIV-associated nephropathy: an urban epidemic. Semin Nephrol 2001; 21: 394-402.
4. Bates W, Seifu L, Walele A. HIV renal disease at Tygerberg Hospital, Western Cape. South African Renal Society Congress, Bloemfontein, July 2002 (Abstract).
5. Freedman BI, Soucie JM, Stone SM, Pegram S. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Am J Kidney Dis 1999; 34: 254-258.
6. Lehner T. The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection. Trends Immunol 2002; 23: 347-351.
7. Schwartz EJ, Cara A, Snoeck H, Ross MD. Human immunodeficiency virus-1 induces loss of contact inhibition in podocytes. J Am Soc Nephrol 2001; 12: 1677-1684.
8. Marras D, Bruggeman LA, Gao F, Tanji N, Mansukhani MM. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med 2002; 8: 522-526.
9. Yamamoto T, Noble NA, Miller DE. Increased levels of transforming growth factor-beta in HIV-associated nephropathy. Kidney Int 1999; 55: 579-592.
10. D'Agati V, Appel GB. Renal pathology of human immunodeficiency virus infection. Semin Nephrol 1998; 18: 406-421.
11. Twahir M, Halkett J, Duffield M. A five years retrospective study of renal biopsy diagnosis in HIV positive patients in Groote Schuur hospital. South African Renal Society Congress, Cape Town, February 2002 (Abstract 17, p. 32).
12. Wali RK, Drachenberg CI, Papadimitriou JC. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet 1998; 352: 783-784.
13. Winston JA, Klotman ME, Klotman PE. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 1999; 55: 1036-1040.
14. Levin ML, Palella F, Shah S. HIV-associated nephropathy occuring before HIV antibody seroconversion. Am J Kidney Dis 2001; 37: E39.
15. Eduardo G, Alfonso M, Luis RJ. Malignant hypertension in HIV patients. Nephrol Dial Transplant 2002; 17: suppl 1, 83.
16. Szczech LA, Gange SJ, van der Horst C, Bartlett JA. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int 2002; 61: 195-202.
17. Border WA, Noble N. Maximizing hemodynamic-independent effects of angiotensin II antagonists in fibrotic diseases. Semin Nephrol 2001; 21: 563-572.
18. Laradi A, Mallet A, Beaufils H. HIV-associated nephropathy: outcome and prognosis factors. Groupe d' Etudes Nephrologiques d'lle de France. J Am Soc Nephrol 1998; 9: 2327-2335.
19. Smith MC, Austen JL, CArey JT, Emancipator SN. Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. Am J Med 1996; 101: 41-48.
20. Szczech LA, Edwards LJ, Sanders LL, van der Horst C. Protease inhibitors are associated with a slowed progression of HIV-related diseases. Clin Nephrol 2002; 57: 336-341.
21. Cosgrove CJ, Abu-Alfa AK, Perazella MA. Observations on HIV-associated renal disease in the era of highly active antiretroviral therapy. Am J Med Sci 2002; 323: 102-106.
22. Ahuja TS, Grady J, Khan S. Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol 2002; 13: 1889-1893.